Persian Validation and Cultural Adaptation of the Body Dysmorphic Disorder Questionnaire-Aesthetic Surgery for Iranian Rhinoplasty Patients

Jahandideh, Hesam; Firouzabadi, Fatemeh Dehghani; Firouzabadi, Mohammad Dehghani; Ashouri, Ahmad; Haghighi, Ali; Roomiani, Maryam

doi:10.52547/wjps.10.2.55

Cited by 8 publications

(5 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Noteworthy that apart from the studies developing and validating these two BDD screening tools, the present search has only found a recent single‐blind cohort study by Spataro et al (2020) using BDDQ‐AS to screen rhinoplasty patients at higher risk for BDD, arguably providing level II evidence 51 . However, the recent upsurge of studies proposing validated versions of these tools in several different languages may soon change this finding 53–56,58–60 …”

Section: Discussionmentioning

confidence: 93%

Evidence‐based review: Screening body dysmorphic disorder in aesthetic clinical settings

Pereira

Chattopadhyay

Fitzpatrick

et al. 2023

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Background: Body dysmorphic disorder (BDD) is a psychiatric disturbance with high incidence in aesthetic clinical settings. Early recognition may avoid unnecessary elective procedures with ethical and medicolegal consequences. Aims:To identify validated BDD screening tools and critically appraise current literature regarding its implementation and efficacy in aesthetic medicine and surgery scenarios, with the purpose of transposing the findings to the broad clinical settings in the field. Methods: Data was collected using advanced search from PubMed (MEDLINE). Having satisfied the search parameters, 12 studies referring BDD definition according to Diagnostic and Statistical Manual of Mental Disorder (DSM-5) criteria and including a BDD screening tool in clinical aesthetic settings were selected. Results: While BDD screening enables the recognition of at-risk individuals, further work is required to uncover the best screening tool for general aesthetic clinical practice. Level III evidence favored BDD Questionnaire (BDDQ)/BDDQ-Dermatology Version (DV), and The Dysmorphic Concern Questionnaire (DCQ) among the limited available validated screening instruments to be used outside the psychiatric environment. Based on level II self-classification, one study selected BDDQ-Aesthetic Surgery (AS) version for rhinoplasty patients. The validation process of both BDDQ-AS and Cosmetic Procedure Screening Questionnaire (COPS) had limitations. For BDD screening potential in avoiding postoperative complications, the limited studies found evaluating the outcomes following aesthetic treatments using validated BDD screening measures showed a trend toward less satisfaction with aesthetic treatment outcome among positive screening population against non-BDD counterparts. Conclusion:Further research is necessary to establish more effective methods to identify BDD and evaluate the impact of positive findings on aesthetic intervention outcomes. Future studies may elucidate which BDD characteristics best predict a favorable outcome and provide high-quality evidence for standardized protocols in research and clinical practice.

show abstract

Section: Discussionmentioning

confidence: 93%

Evidence‐based review: Screening body dysmorphic disorder in aesthetic clinical settings

Pereira

Chattopadhyay

Fitzpatrick

et al. 2023

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

“…To date, no prevalence study of BDD has been conducted in the general population in Iran, but some subpopulations can be compared between Iran and combined samples from other countries. Prevalences seem to be higher in rhinoplastic [36][37][38][39][40], orthognathic [41] and dermatological [42] patients compared to a global sample [18]. In a student sample, the prevalence was somewhat greater in Iran [4.5%, 43] than in a combined sample of different nationalities [3.3%, 18].…”

Section: Culture Comparisonmentioning

confidence: 99%

Validation of a German Body Dysmorphic Disorder Screening Scale and Clinical Interview according to ICD-11 and DSM-5 in the General Population

Schüller,

Ebert,

Tavakoli

et al. 2024

Preprint

View full text Add to dashboard Cite

Background Body dysmorphic disorder (BDD) is an impairing psychological disorder with a high prevalence in clinical and cosmetic surgery settings. In the new ICD-11, BDD is grouped with the obsessive-compulsive spectrum disorders and the diagnostic criteria are updated, largely corresponding with the DSM-5. Available diagnostic interviews and screening scales for BDD are not based on these current criteria. In this paper, a newly developed screening questionnaire (BDD-S) and structured clinical interview (BDD-CI) according to the ICD-11 and DSM-5 criteria were preliminarily validated. Methods The BDD-S and the BDD-CI cover all core BDD symptoms. Open-ended questions allow for the addition of qualitative information on affected body parts and behavioural and mental aspects. We determined the internal consistency and construct validity of the BDD-S and suggested a cutoff value. We assessed a subsample with the BDD-CI and estimated a prevalence. The BDD-S was translated into Farsi and applied to an Iranian sample. BDD-S scores, social anxiety symptoms, and general psychopathological impairment were compared between a German and an Iranian sample. Results Internal consistency of the BDD-S was excellent (ω = .92). A high correlation with the body dysmorphic concerns and moderate correlations with measures of other mental disorders supported good construct validity. We determined a cutoff value of 19 for balanced sensitivity and specificity (sensitivity = 0.92, specificity = 0.87, AUC = .94). We estimated a prevalence of 2.76% for the German sample. The cultural comparison showed that the BDD-S score was higher in the Iranian sample. Conclusions With the BDD-S, we developed an economic and versatile screening instrument based on current diagnostic criteria, to be followed up with the BDD-CI when applicable, to obtain a clinical diagnosis. In the next step, the measures must be validated in larger clinical samples.

show abstract

“…12 The BDDQ-AS has been validated in different languages. 13,14 The Body Dysmorphic Symptoms Scale is a 10-item selfreport measurement assessing psychopathological symptoms of BDD. Whereas the psychometric properties of the original version of the BDSC were not assessed, a recent Brazilian version of the BDSS was validated in a population sample of 80 cosmetic rhinoplasty patients.…”

Section: Picavetmentioning

confidence: 99%

Novel Selection Tools in Rhinoplasty Patients

et al. 2022

View full text Add to dashboard Cite

With no consensus document or guideline to help us compute the psychological make-up of rhinoplasty candidates and in the light of new perspectives of some key opinion leaders in the field of patient selection, the goals of this article are to offer a glimpse of the current literature together with the knowledge gaps, introduce some new tools for the preoperative consultation, help us identify who among our patients is at greatest risk for a poor outcome, and explain how childhood trauma can be linked to body shame and postoperative dissatisfaction.

show abstract

Persian Validation and Cultural Adaptation of the Body Dysmorphic Disorder Questionnaire-Aesthetic Surgery for Iranian Rhinoplasty Patients

Cited by 8 publications

References 12 publications

Evidence‐based review: Screening body dysmorphic disorder in aesthetic clinical settings

Evidence‐based review: Screening body dysmorphic disorder in aesthetic clinical settings

Validation of a German Body Dysmorphic Disorder Screening Scale and Clinical Interview according to ICD-11 and DSM-5 in the General Population

Novel Selection Tools in Rhinoplasty Patients

Contact Info

Product

Resources

About